Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
NCT ID: NCT00768898
Last Updated: 2012-04-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Staining in a Healthy, Non-Dry Eye Population
NCT00643942
Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients
NCT00799422
Optimization of Assessment and Grading for Lid Wiper Epitheliopathy
NCT01611922
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
NCT00483795
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
NCT00381446
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2.5 microliters lissamine green
2.5/5.0/10.0 µL lissamine green
vital stain solution
5.0 microliters lissamine green
2.5/5.0/10.0 µL lissamine green
vital stain solution
10.0 microliters lissamine green
2.5/5.0/10.0 µL lissamine green
vital stain solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2.5/5.0/10.0 µL lissamine green
vital stain solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-08-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.